Dr. Harsh Vardhan unveils National Biotechnology Development Strategy 2015-2020

India Infoline News Service | Mumbai | December 30, 2015 16:36 IST

The National Biotechnology Development Strategy 2015-20 aims to establish India as a world-class bio-manufacturing hub. It intends to launch a major mission, backed with significant investments, for the creation of new biotech products, create a strong infrastructure for R&D and commercialization, and empower India’s human resources scientifically and technologically

The National Biotechnology Development Strategy 2015-20 was unveiled today by the Hon’ble Minister for Science & Technology and Earth Sciences, Dr. Harsh Vardhan, and the Hon’ble Minister of State for Science & Technology and Earth Sciences, Shri. YS Chowdary, in the presence of the Secretary, Department of Biotechnology, Dr. VijayRaghavanand other key stakeholders.

The National Biotechnology Development Strategy 2015-20 aims to establish India as a world-class bio-manufacturing hub. It intends to launch a major mission, backed with significant investments, for the creation of new biotech products, create a strong infrastructure for R&D and commercialization, and empower India’s human resources scientifically and technologically.
 
Said Minister for Science & Technology and Earth Sciences, Dr. Harsh Vardhan: “The Department of Biotechnology is going to soon complete 30 years. It has done commendable work over the years in catalyzing the growth of the biotechnology industry, which has a huge potential to positively impact the lives of Indians in every area, such as research, education, health, technology, and energy. This was sensed a long time ago by the Government. When Shri Atal Bihari Vajpayee was the prime ministry, he used to say that while IT (information technology) stands for ‘India Today,’ BT (biotechnology) stands for ‘Bharat Tomorrow.’ I believe this industry has the potential to grow like the IT industry over the next ten years and beyond. The development of the inexpensive rotavirus vaccine, available for less than a dollar in India when internationally it costs 50 dollars, is an example of what can be achieved by the Indian biotechnology industry. Several other vaccines, such as for dengue and malaria, are already under development. The growth prospects of the Indian biotechnology industry are bright provided it receives the right stimulus and an enabling environment.”
 
Added the Secretary, Department of Biotechnology, Dr. VijayRaghavan: “India stands at an extraordinary position in science and technology. Our challenge is to build on this foundation to see how to take the country further. Biotechnology has an important part to play in India’s growth story and there is enthusiastic support from the Government for this vision. We have drafted a very ambitious strategy with the target to turn biotechnology into a US $100bn industry by 2025. I believe this is not impossible to achieve. Several growth opportunity exists. For example, many low-end products can be successfully manufactured in India. Our challenge is to stimulate the industry players to make them partner internationally in developing these products at the fraction of the cost of what is possible outside India, and the sell them nationally as well as globally. A huge opportunity exists in the manufacture of diagnostic kits too.”
 

Advertisements

  • Save upto Rs.2.67 lakh with Pradhan Mantri Awas Yojana ...Know more
  • Now Save Rs.3150 on your Demat Account ...Click here
  • Now get IIFL Personal Loan in just 8* hours...APPLY NOW!
  • Get the most detailed result analysis on the web - Real Fast!
  • Actionable & Award-Winning Research on 500 Listed Indian Companies.